Antiseizure medicines: selection, adverse effects and monitoring — branching viva

Opening question

A ten-year-old boy with focal epilepsy is two weeks into levetiracetam and his parents report new irritability and aggression. His seizures are controlled. Classify the drug by spectrum and mechanism, explain the behavioural adverse effect and its approximate frequency, and outline your management. [5] [1]

Branch 1 — the spectrum rule

The family asks whether the uncle's carbamazepine could be used instead. What is the spectrum classification of carbamazepine, why is it appropriate for focal epilepsy, and what syndrome must it never be given for? [1] [5]

Branch 2 — the valproate pregnancy prevention programme

Fast forward: a fourteen-year-old girl with juvenile myoclonic epilepsy needs valproate for optimal control. What is the valproate pregnancy prevention programme, what conditions must be met before prescribing, and what are the preferred alternatives in a female of childbearing potential? [7] [5]

Branch 3 — the lamotrigine rash scenario

If lamotrigine is chosen as the alternative, what is the titration rule, why does concurrent valproate require an even slower titration, and what is the severe cutaneous adverse effect the slow titration prevents? [11]

Closing — monitoring and coordination

In one sentence, what is the principle of managing antiseizure medicines across childhood — selecting by the syndrome, titrating slowly, surveying the adverse-effect signature at every visit, and referring for presurgical evaluation after two failed drugs — and why does the general paediatrician sit at the centre of the plan? [1] [5]